Item 7.01 Regulation FD Disclosure. On March 23, 2026, Core Laboratories Inc. issued a press release announcing revisions to previously issued earnings guidance for the first quarter of 2026. The full text of the press release is set forth in Exhibit 99.1 attached hereto. The information in this Report and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly stated by specific reference in such filing.
CLB Core Laboratories Inc. /De/ - 8-K
Accession
0001193125-26-1199347.019.01
Item 7.01 - Regulation FD Disclosure
111 words
Item 9.01 - Financial Statements and Exhibits
49 words
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Press release issued on March 23, 2026 * 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * This exhibit is intended to be furnished and shall not be deemed “filed” for purposes of the Exchange Act.